論文・技術情報追加のお知らせ

①Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database.

選択的セロトニン再取り込み阻害薬と横紋筋融解症リスクとの関連性調査研究

対象DB：FAERS

②Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database.

テストステロン補充治療と心血管系有害事象との関連性調査研究

対象DB：FAERS

③Cardiovascular Adverse Events Associated With New-Generation Androgen Receptor Pathway Inhibitors (ARPI) for Prostate Cancer: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS).

前立腺癌治療における新世代ARPIと心血管系有害事象との関連性評価研究

対象DB：FAERS

④Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases.

エソメプラゾールおよびオメプラゾールの併用使用時における、合併症発症リスク評価研究

対象DB：FAERS、JADER

⑤A Summary of the Rare Reports of Osteonecrosis of the Jaw Associated With Tumor Necrosis-alpha Inhibitors in the United States Food and Drug Administration's Adverse Event Reporting System Database.

抗TFN薬と顎骨壊死との関連性調査研究

対象DB：FAERS

⑥Peripheral Neuropathy Potentially Associated to Poly (ADP-Ribose) Polymerase Inhibitors: An Analysis of the Eudravigilance Database.

PARP阻害剤と末梢神経障害との関連性調査研究

対象DB：EudraVigilance